Private equity firm Celtic Pharma is launching two new funds worth $1.5 billion in total, to invest in development-stage biotech companies and products.

Consumer products giant Procter and Gamble is applying its knowledge of consumers to the development of new medicines – and wants to share its insights with biotech companies.

Follow the fashion: the biotech financing model has changed. But will today’s start-ups be tomorrow’s fashion victims?

Today France Biotech celebrates its tenth birthday at the Eurobio Show in Lille. And the picture has never been rosier.

Nordforsk, the funding agency of the Nordic Council of Ministers, has funded the coordination of a network on biomedical imaging.

After a decade of withering in the shade of genetically modified crops, plant sciences are back on the political agenda in Europe follow the launch this week of a new Strategic Research Agenda.

India’s biotech sector is powering ahead, with 30 per cent annual growth over the past four years. But venture capitalists are still not tempted to invest.

The claim that over-patenting hinders the development of new treatments is not supported by the evidence, says the US Biotechnology Industry Organization.